Acarbose and Naproxen drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Acarbose (acarbose) and Naproxen (naproxen). Common drug interactions include gastric polyps among females and pseudolymphoma among males.
The phase IV clinical study analyzes what interactions people have when they take Acarbose and Naproxen. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.
What is Acarbose?
Acarbose has active ingredients of acarbose. It is often used in diabetes. eHealthMe is studying from 4,605 Acarbose users. Check the latest studies of Acarbose.
What is Naproxen?
Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 72,033 Naproxen users. Check the latest studies of Naproxen.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
35 people who take Acarbose and Naproxen together, and have interactions are studied.

What are the common drug interactions of Acarbose and Naproxen, by gender? *:
female:
- Gastric polyps (abnormal growth of stomach tissue projecting from a mucous membrane)
- Fall
- Gastritis (inflammation of stomach)
- Neuroendocrine tumour (a tumour that forms from cells that release hormones into the blood in response to a signal from the nervous system)
- Pruritus (severe itching of the skin)
- Psoriasis (immune-mediated disease that affects the skin)
- Rash erythematous (redness of the skin)
- Rib fracture
- Blood glucose decreased
- Blood pressure decreased
male:
- Pseudolymphoma (group of disorders having a benign course but exhibiting clinical and histological features suggestive of malignant lymphoma)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
- Drug eruption (adverse drug reaction of the skin)
- Dysarthria (speech disorder)
- General physical health deterioration (weak health status)
- Hypercholesterolaemia (high levels of cholesterol in the blood)
- Incoherent (talking in a confused and unclear way)
- Nausea (feeling of having an urge to vomit)
- Pancreatic carcinoma (pancreatic cancer)
- Pruritus (severe itching of the skin)
What are the common drug interactions of Acarbose and Naproxen, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Cellulitis (infection under the skin)
40-49:
- Abdominal pain
- Pancreatitis (inflammation of pancreas)
50-59:
- Blood pressure decreased
- Device related infection
- Dysphagia (a condition in which swallowing is difficult or painful)
- Fall
- Feeding tube complication
- Pruritus (severe itching of the skin)
- Psoriasis (immune-mediated disease that affects the skin)
- Rash erythematous (redness of the skin)
- Rash pustular (redness with pustules)
- Rib fracture
60+:
- Pseudolymphoma (group of disorders having a benign course but exhibiting clinical and histological features suggestive of malignant lymphoma)
- Gastric polyps (abnormal growth of stomach tissue projecting from a mucous membrane)
- Abdominal pain upper
- Aphasia (damage to the parts of the brain that control language)
- Arrhythmia (irregular heartbeat)
- Arthralgia (joint pain)
- Carcinoid tumour (slow growing tumour)
- Carcinoid tumour of the stomach
- Chronic kidney disease
- Drug eruption (adverse drug reaction of the skin)
What are the existing conditions these people have? *
- Immunodeficiency Common Variable: 7 people, 20.00%
- Enlarged Prostate: 6 people, 17.14%
- Type 2 Diabetes: 4 people, 11.43%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 8.57%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 8.57%
- High Blood Pressure: 3 people, 8.57%
- High Blood Cholesterol: 3 people, 8.57%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.71%
* Approximation only. Some reports may have incomplete information.
Do you take Acarbose and Naproxen?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Acarbose and Naproxen:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Acarbose:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Naproxen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Acarbose and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Naproxen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on acarbose and naproxen (the active ingredients of Acarbose and Naproxen, respectively), and Acarbose and Naproxen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lidocaine Hydrochloride cause Bradycardia? - 10 seconds ago
- Could Lexapro cause Precancerous Cells Present? - 11 seconds ago
- Paragard T 380A vs. Depo-Subq Provera 104, side effect and effectiveness comparison - 19 seconds ago
- Could Levothyroxine Sodium cause Aortic Calcification? - 23 seconds ago
- Could Tradjenta cause Jaundice - Yellow Skin? - 25 seconds ago
- Could Lexiva cause Depression? - 26 seconds ago
- Could Tracleer cause Angioplasty? - 29 seconds ago
- Formoterol Fumarate and Rashes for Girls aged 10-19 - 30 seconds ago
- Formoterol Fumarate and Rash Generalised for Girls aged 10-19 - 30 seconds ago
- Formoterol Fumarate and Rash for Girls aged 10-19 - 30 seconds ago